TC Biopharm (TCBP) Short-Term Debt to Capital
TC Biopharm (TCBP) faces significant challenges due to the high cost of T-cell production and reliance on British regulators. This valuation chart reflects the indicator 0.25. The business relies on the development of allogeneic tumor-fighting methods while awaiting primary test data. Growth prospects are tied to the safety of the OmnImmune platform in treating leukemia without the need for donor matching.
Metric breakdowns and analytics for tcbiopharm.com (TCBP)
- price and consensus price forecast:
- market capitalization data:
- book capitalization data:
- debt and liquidity data:
Comprehensive company analysis:TC BioPharm (Holdings) PLC, TCBP
Developing innovative T-cell therapy requires significant expenditures; therefore, analyzing the share of short-term loans within the capital structure allows for an assessment of TC Biopharm (TCBP) dependence on operational borrowing relative to its equity. The trend of this ratio reveals liquidity risk when searching for a fundamental bottom, where a reduction in debt load minimizes the probability of bankruptcy but may signal developmental stagnation.
Competing companies
Argenx (ARGX) - Short-Term Debt to Capital|Ratio of Short-Term Indebtedness to Capital BioNTech Pharma (BNTX)|Short-Term Debt to Capital ABVX (Abivax Pharma)|admabiologics.com - Short-Term Debt to Capital|Short-Term Debt to Equity Protagonist (PTGX)|IMVT: Ratio of Short-Term Indebtedness to Capital|KNSA (Kiniksa Pharmaceuticals Ltd) - Short-Term Debt to Equity|Grifols Biemat (GRFS) - Short-Term Debt to Equity Ratio|ADPT (Adaptive Biotechnologies) - Short-Term Debt to Capital|Short-Term Debt to Capital celldex.com (CLDX)|Aurinia Pharmaceuticals Inc. (AUPH) - Short-Term Debt to Equity Ratio|Ratio of Short-Term Indebtedness to Capital BioCryst Pharmaceuticals, Inc. (BCRX)|Short-Term Debt to Capital VERA|Dianthus Corp - Short-Term Debt to Capital Coefficient|PHVS: Short-Term Debt to Equity|ABCL: Short-Term Debt to Equity Ratio|TRML (Tourmaline Bio) - Short-Term Debt to Equity|Short-Term Debt to Equity Ratio Precigen Inc|PHAR (Pharming) - Short-Term Debt to Equity Ratio|Short-Term Debt to Capital NKTR|Short-Term Debt to Equity Upstream Bio Inc UPB|Short-Term Debt to Capital Ratio zenasbio.com (ZBIO)|IMNM: Short-Term Debt to Capital|GOSS - Current Liabilities to Capital|Short-Term Debt to Equity Ratio KalVista Pharmaceuticals Inc KALV|SEPN - Short-Term Loans to Capital Ratio|PVLA (Pieris Pharmaceuticals) - Short-Term Debt to Capital|Short-Term Debt to Equity Ratio savarapharma.com|RIGL - Short-Term Debt to Equity Ratio|Ratio of Short-Term Indebtedness to Capital AnaptysBio Inc|Short-Term Debt to Capital Astria Pharma (ATXS)|Short-Term Debt to Equity enGene Corp (ENGN)|Short-Term Debt to Capital RAPT|Aerovate Therapeutics, Inc. - Short-Term Debt to Capital Coefficient|ACRS (Aclaris Therapeutics, Inc.) - Short-Term Debt to Equity|KYTX: Current Liabilities to Capital|Short-Term Debt to Equity Tiziana Life Sciences PLC (TLSA)|Cabaletta Bio Inc (CABA) - Current Liabilities to Equity|VTYX - Short-Term Debt to Capital|Ratio of Short-Term Indebtedness to Capital theratech.com|Short-Term Debt to Capital AVTX|Short-Term Debt to Capital ELDN (Eledon Pharmaceuticals Inc.)|Short-Term Debt to Equity Agenus Inc|Climb Bio, Inc - Ratio of Short-Term Indebtedness to Capital|ZURA: Short-Term Debt to Equity|atyrpharma.com (ATYR) - Short-Term Debt to Equity Ratio|ADAG - Short-Term Debt to Equity Ratio|Ikena Oncology (IMA) - Short-Term Loans to Capital Ratio|Short-Term Debt to Capital STTK|Short-Term Debt to Equity Ratio Equillium Bio|Short-Term Debt to Capital Connect Biopharma (CNTB)|Short-Term Debt to Equity IMUX (immunic-therapeutics.com)|Atara Bio (ATRA) - Short-Term Debt to Equity|InflaRx NV - Current Liabilities to Equity|Short-Term Debt to Equity X4 Pharma|ACET - Current Liabilities to Equity|Short-Term Debt to Capital celularity.com CELU|inmunebio.com (INMB) - Ratio of Short-Term Indebtedness to Capital|BRNS (Barinthus Biotherapeutics plc) - Short-Term Debt to Capital|Short-Term Debt to Capital KZR|SAB Biotherapeutics, Inc (SABS) - Short-Term Debt to Equity|Ratio of Short-Term Indebtedness to Capital AKTX (Akari Therapeutics, Plc)|Enlivex Therapeutics Ltd. - Short-Term Debt to Equity|Short-Term Debt to Equity Ratio Q32 Bio Inc QTTB|GeoVax - Short-Term Debt to Capital|Edesa Biotech Inc (EDSA) - Short-Term Debt to Capital|Short-Term Debt to Equity Ratio iBio Corp IBIO|Carisma Therapeutics Inc. (CARM) - Ratio of Short-Term Indebtedness to Capital|XTLB: Short-Term Debt to Capital|Short-Term Debt to Capital Coefficient BOLT|Short-Term Debt to Equity HCWB (HCW Biologics Inc.)|Short-Term Debt to Equity Ratio APVO (aptevotherapeutics.com)|AIM ImmunoTech Inc. - Short-Term Debt to Equity|ADTX - Short-Term Debt to Equity Ratio|GRI Bio, Inc. - Short-Term Debt to Equity Ratio|XRTX: Short-Term Debt to Capital|Short-Term Debt to Equity Vyome Holdings|Revelation Biosciences Inc (REVB) - Short-Term Debt to Capital Ratio|Short-Term Debt to Capital INDP (Indaptus)|Current Liabilities to Capital BiondVax Pharmaceuticals (SCNI)|Short-Term Debt to Equity Ratio CalciMedica, Inc.|Short-Term Loans to Capital Ratio affimed.com (AFMD)|Allakos - Short-Term Debt to Capital|HOOK - Short-Term Debt to Equity Ratio|Short-Term Debt to Equity Ratio IGM Bio (IGMS)|ITOS - Ratio of Short-Term Indebtedness to Capital|Ocean Biomedical, Inc. (OCEA) - Short-Term Debt to Capital|thirdharmonicbio.com (THRD) - Short-Term Debt to Equity